Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Korro Bio, Inc. Director's Dealing 2023

Nov 8, 2023

33032_dirs_2023-11-07_0ab253fc-b7ba-4775-951f-24cff8fffc39.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Korro Bio, Inc. (KRRO)
CIK: 0001703647
Period of Report: 2023-11-03

Reporting Person: Bermingham Nessan (N/A)

More from Korro Bio, Inc.

Regulatory Filings 2026
May 19
Regulatory Filings 2026
May 12
Interim / Quarterly Report 2026
May 7
Regulatory Filings 2026
May 7
Annual Report 2026
Apr 16
Proxy Solicitation & Information Statement 2026
Apr 16
Regulatory Filings 2026
Mar 23
Regulatory Filings 2026
Mar 20
Major Shareholding Notification 2026
Feb 17
Major Shareholding Notification 2026
Feb 17
View all filings →